Successful non-operative management of right coronary artery perforation during percutaneous coronary intervention in a patient receiving abciximab and aspirin

Journal of Invasive Cardiology

Volumn 12, Issue 1, 2000, Pages 41-43

  Del Campo, Carlos ^a,b   Zelman, Robert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Abciximab; Angina; Coronary artery perforation; Liver cirrhosis; Percutaneous transluminal coronary angioplasty

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; FOLLOW UP; HUMAN; INJURY; MALE; PENETRATING TRAUMA; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ASPIRIN; CORONARY DISEASE; CORONARY VESSELS; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; TREATMENT OUTCOME; WOUNDS, PENETRATING;

EID: 0033629806     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Cowley MJ, Dorros G, Kesley SF, et al. Acute coronary events associated with percutaneous transluminal coronary angioplasty. Am J Cardiol 1984;53(Suppl C):12C.
2. Ellis SG, Ajluni L, Arnold AZ, et al. Increased coronary perforation in the new device era. Incidence, classification, management and outcome. Circulation 1994;90:2725-2730.
3. Tcheng J, Ellis SG, George BS. Pharmacodynamics of chimeric glycoprotein IIB/IIIa integrin antiplatelet antibody Fab 7E3 in high risk coronary angioplasty. Circulation 1994;89:596-603.
4. Ballard HS, Marcus AJ. Platelet aggregation in portal cirrhosis. Arch Intern Med 1976;136:316-319.
5. Kereiakes DJ, Broderick TM, Whang DD, et al. Partial reversal of heparin anticoagulant by intravenous protamine in abciximab-treated patients undergoing percutaneous intervention. Am J Cardiol 1997;80:633-634.
6. Briguori C, DiMario C, DeGregorio J, et al. Administration of protamine after coronary stent deployment. Am Heart J 1999;138:64-68.
7. Juergens CP, Yeung AC, Oesserle SN. Routine platelet transfusion in patients undergoing emergency coronary bypass surgery after receiving abciximab. Am J Cardiol 1997;80:74-75.
8. Kereiakes DJ. Prophylactic platelet transfusion in patients requiring emergency coronary bypass surgery. Am J Cardiol 1998;81:373.